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ABSTRACT 
High prolactin levels during breast-feeding, is recognized to influence metabolism in order to supply 
glucose and fat for milk production. Pathologic overproduction of prolactin, hyperprolactinemia, is a 
condition primarily associated with reproductive disorders; however, the metabolic impact of elevated 
prolactin indicates that these parameters might be considered in clinical management of the condition. 
Prolactin receptors have previously not been demonstrated in human adipose tissue, and prolactin-
related effects in adipose tissue, therefore, were regarded as indirect. This thesis focuses on the 
demonstration of prolactin receptors in human adipose tissue, and the metabolic function of prolactin 
stimulation in vitro and in vivo.
We have demonstrated the expression of four prolactin receptor isoforms in human adipose tissue, the 
L-, I-, s1a- and s1b-prolactin receptors. Prolactin stimulation of cultured human adipose tissue in vitro
was found to reduce lipoprotein lipase activity, and thereby likely diminishes the ability for fat 
uptake. Furthermore, lipogenic parameters such as glucose transporter 4 expression and malonyl-CoA 
concentration in the cultured adipose tissue were also found to be suppressed by prolactin. The 
insulin-sensitizing hormone adiponectin is secreted from adipose tissue, and prolactin stimulation 
during culture suppressed adiponectin secretion. These results were confirmed in female prolactin 
transgenic mice, which were observed to have suppressed adiponectin serum levels. The effects of 
prolactin were further investigated in an initiated study of hyperprolactinemic women in vivo. By 
using indirect calorimetry, these women were demonstrated to have a decreased fat oxidation. 
Based on the results of this thesis and other studies, there are indications that prolactin could be a 
potent and specific regulator of several metabolic processes. The regulation of nutrient flux is 
important to maintain a balanced metabolism. The metabolic effects in hyperprolactinemia are often 
overlooked in clinical practice, but we find further investigations motivated in order to clarify the 
magnitude of metabolic effects in hyperprolactinemia. 
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